/PRNewswire/ The global lung cancer therapeutics market size is estimated to grow by USD 10.52 billion from 2024-2028, according to Technavio. The market is.
Large companies are bolstering their adjusted earnings per share by excluding items such as litigation expenses and amortization of intangible assets from their net income.